Insider Buying: Beyond Air, Inc. (NASDAQ:XAIR) Director Buys 10,000 Shares of Stock

Beyond Air, Inc. (NASDAQ:XAIRGet Rating) Director Robert Carey bought 10,000 shares of the stock in a transaction that occurred on Wednesday, November 16th. The shares were purchased at an average cost of $6.00 per share, for a total transaction of $60,000.00. Following the completion of the acquisition, the director now owns 752,323 shares of the company’s stock, valued at $4,513,938. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Robert Carey also recently made the following trade(s):

  • On Friday, November 18th, Robert Carey bought 20,000 shares of Beyond Air stock. The shares were purchased at an average cost of $5.80 per share, for a total transaction of $116,000.00.

Beyond Air Stock Up 1.6 %

NASDAQ:XAIR opened at $5.81 on Monday. The business’s 50-day moving average price is $7.26 and its 200 day moving average price is $7.63. The firm has a market cap of $173.78 million, a P/E ratio of -3.25 and a beta of -0.12. Beyond Air, Inc. has a 52-week low of $4.78 and a 52-week high of $16.41.

Beyond Air (NASDAQ:XAIRGet Rating) last released its earnings results on Tuesday, November 8th. The company reported ($0.40) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.36) by ($0.04). Sell-side analysts expect that Beyond Air, Inc. will post -1.52 EPS for the current year.

Hedge Funds Weigh In On Beyond Air

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. State Street Corp boosted its position in shares of Beyond Air by 5.0% in the 3rd quarter. State Street Corp now owns 88,007 shares of the company’s stock valued at $655,000 after purchasing an additional 4,200 shares during the period. Vanguard Group Inc. boosted its position in shares of Beyond Air by 0.9% in the 3rd quarter. Vanguard Group Inc. now owns 1,131,763 shares of the company’s stock valued at $8,420,000 after purchasing an additional 9,617 shares during the period. Parkman Healthcare Partners LLC acquired a new position in shares of Beyond Air in the 3rd quarter valued at $941,000. BlackRock Inc. boosted its position in shares of Beyond Air by 7.5% in the 3rd quarter. BlackRock Inc. now owns 286,128 shares of the company’s stock valued at $2,129,000 after purchasing an additional 19,930 shares during the period. Finally, Cubist Systematic Strategies LLC acquired a new position in shares of Beyond Air in the 3rd quarter valued at $198,000. Institutional investors and hedge funds own 16.45% of the company’s stock.

Beyond Air Company Profile

(Get Rating)

Beyond Air, Inc operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria.

Recommended Stories

Insider Buying and Selling by Quarter for Beyond Air (NASDAQ:XAIR)

Receive News & Ratings for Beyond Air Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beyond Air and related companies with MarketBeat.com's FREE daily email newsletter.